Mittelman A, Denny T, Gebhard D, Cirrincione C, Kurland E, Koziner B
Am J Hematol. 1984 Jan;16(1):67-73. doi: 10.1002/ajh.2830160109.
T-cell subsets were determined by the Leu monoclonal antibodies in the peripheral blood and/or bone marrow of 52 patients with B-cell chronic lymphocytic leukemia (B-CLL) not on therapy at the time of study. The diagnosis of B-CLL required that the leukemic cells expressed surface receptors for "la-like" antigen, Fc fragment of IgG, mouse red blood cells (MRBC), C3-coated red cells (EAC), and low density of monoclonal surface immunoglobulin. The Leu-3a+/2a+ ratio was applied to define the balance between the helper/suppressor subsets in the residual T-lymphocytes. Most patients showed a decrease in the Leu-3a+/2a+ ratios at all stages of disease. The decrease in ratio was mainly related to a decrease in the Leu-3a+ T-cell subset. The more advanced stages of B-CLL were associated with lower Leu-3a+/2a+ ratio, higher total white cell and percent lymphocyte counts. There was no correlation between the proportion of EAC or MRBC rosetting cells and stages of B-CLL. This analysis further suggests that B-CLL is an immunosuppressed state that becomes more pronounced in the advanced stages and is characterized by a progressive decrease in the Leu-3a+ (helper) T-cell subset.
采用Leu单克隆抗体对52例研究时未接受治疗的B细胞慢性淋巴细胞白血病(B-CLL)患者的外周血和/或骨髓中的T细胞亚群进行测定。B-CLL的诊断要求白血病细胞表达“类la”抗原、IgG的Fc片段、小鼠红细胞(MRBC)、C3包被红细胞(EAC)的表面受体,以及低密度的单克隆表面免疫球蛋白。应用Leu-3a+/2a+比值来确定残余T淋巴细胞中辅助/抑制亚群之间的平衡。大多数患者在疾病的各个阶段Leu-3a+/2a+比值均降低。比值降低主要与Leu-3a+ T细胞亚群减少有关。B-CLL的晚期与较低的Leu-3a+/2a+比值、较高的白细胞总数和淋巴细胞百分比相关。EAC或MRBC玫瑰花结形成细胞的比例与B-CLL的分期之间无相关性。该分析进一步表明,B-CLL是一种免疫抑制状态,在晚期更为明显,其特征是Leu-3a+(辅助)T细胞亚群逐渐减少。